Acadia Healthcare Company, Inc.
ACHC · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $851,573 | $869,232 | $770,505 | $774,238 |
| % Growth | -2% | 12.8% | -0.5% | – |
| Cost of Goods Sold | $30,412 | $28,532 | $519,320 | $28,560 |
| Gross Profit | $821,161 | $840,700 | $251,185 | $745,678 |
| % Margin | 96.4% | 96.7% | 32.6% | 96.3% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $525,383 | $514,988 | $45,707 | $484,787 |
| SG&A Expenses | $525,383 | $514,988 | $45,707 | $484,787 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $176,255 | $183,409 | $192,010 | $157,429 |
| Operating Expenses | $701,638 | $698,397 | $237,717 | $642,216 |
| Operating Income | $119,523 | $142,303 | $13,468 | $103,462 |
| % Margin | 14% | 16.4% | 1.7% | 13.4% |
| Other Income/Exp. Net | -$79,538 | -$92,300 | $0 | -$65,454 |
| Pre-Tax Income | $39,985 | $50,003 | $13,468 | $38,008 |
| Tax Expense | $1,668 | $12,067 | $4,404 | $4,479 |
| Net Income | $36,246 | $30,127 | $8,374 | $32,615 |
| % Margin | 4.3% | 3.5% | 1.1% | 4.2% |
| EPS | 0.4 | 0.33 | 0.09 | 0.36 |
| % Growth | 21.2% | 266.7% | -75% | – |
| EPS Diluted | 0.4 | 0.33 | 0.09 | 0.35 |
| Weighted Avg Shares Out | 90,414 | 90,328 | 91,654 | 91,769 |
| Weighted Avg Shares Out Dil | 90,584 | 90,435 | 92,038 | 91,986 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $36,619 | $35,138 | $29,182 | $30,071 |
| Depreciation & Amortization | $47,468 | $48,995 | $48,088 | $39,541 |
| EBITDA | $124,072 | $134,136 | $90,738 | $107,620 |
| % Margin | 14.6% | 15.4% | 11.8% | 13.9% |